Genflow Biosciences moves forward on MASH trial - ICYMI
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) outlined recent developments across its pipeline following the release of its 2024 results. The company said it had made progress on multiple fronts, including its core MASH program, additional indications …